Real-World Faricimab for Treatment-Naïve Neovascular AMD and Diabetic Macular Edema: 24-Month Outcomes from a Single-Center Pilot Cohort in South-Eastern Europe.

For CFT, the time effect was highly significant (β = −5.57 μm per month, p < 0.001), whereas neither the group main effect (β = −12.55 μm, p = 0.70) nor the time × group interaction (β = −0.43 μm per month, p = 0.84) was significant.

also in 132,142 other papers